Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to study ST000694 main page
Show: (1)
HMDB and KEGG pathways
(2)
REACTOME pathways
containing these metabolites
Select
Metabolite Name
Metabolite Id
Refmet Name
Ret. Index
Quant. m/z
Analysis Display
11-DEOXYCORTISOL (CAS# 152-58-9); (M+CL)-
ME194701
11-Deoxycortisol
15.529
346.2175
Reversed phase NEGATIVE ION MODE
11-DEOXYCORTISOL (CAS# 152-58-9); (M+HCOO)-
ME194702
11-Deoxycortisol
15.388
346.2115
Reversed phase NEGATIVE ION MODE
17ALPHA-HYDROXYPROGESTERONE (CAS# 68-96-2); (M+CL)...
ME194705
17alpha-Hydroxyprogesterone
17.845
330.2228
Reversed phase NEGATIVE ION MODE
3BETA-HYDROXY-5ALPHA-PREGNAN-20-ONE (CAS# 516-55-2...
ME194732
3beta-Hydroxy-5alpha-pregnan-20-one
20.803
318.2581
Reversed phase NEGATIVE ION MODE
3BETA-HYDROXYANDROST-5-EN-17-ONE 3-SULFATE (CAS# )...
ME194733
Dehydroepiandrosterone sulfate
15.454
368.1679
Reversed phase NEGATIVE ION MODE
CORTICOSTERONE (CAS# 50-22-6); (M+CL)-
ME194806
Corticosterone
15.709
346.2169
Reversed phase NEGATIVE ION MODE
CORTICOSTERONE (CAS# 50-22-6); (M+HCOO)-
ME194807
Corticosterone
15.388
346.2115
Reversed phase NEGATIVE ION MODE
CORTISOL (CAS# 50-23-7); (M+HCOO)-
ME194808
Cortisol
13.741
362.2101
Reversed phase NEGATIVE ION MODE
CORTISONE (CAS# 53-06-5); (M+HCOO)-
ME194809
Cortisone
13.364
360.1941
Reversed phase NEGATIVE ION MODE
11-DEOXYCORTISOL (CAS# 152-58-9); (M+H)+
ME195101
11-Deoxycortisol
15.407
346.2123
Reversed phase POSITIVE ION MODE
11-DEOXYCORTISOL (CAS# 152-58-9); (M+NA)+
ME195102
11-Deoxycortisol
15.386
346.2167
Reversed phase POSITIVE ION MODE
17BETA-HYDROXYANDROSTAN-3-ONE (CAS# 521-18-6); (M+...
ME195106
5alpha-Dihydrotesosterone
18.49
290.2258
Reversed phase POSITIVE ION MODE
3BETA-HYDROXY-5ALPHA-PREGNAN-20-ONE (CAS# 516-55-2...
ME195145
3beta-Hydroxy-5alpha-pregnan-20-one
20.711
318.2575
Reversed phase POSITIVE ION MODE
3BETA-HYDROXYANDROST-5-EN-17-ONE (CAS# 53-43-0); (...
ME195146
Dehydroepiandrosterone
17.276
288.2065
Reversed phase POSITIVE ION MODE
ALDOSTERONE (CAS# 52-39-1); (M+H)+[-H2O]
ME195188
Aldosterone
12.373
360.1907
Reversed phase POSITIVE ION MODE
ANDROSTERONE (CAS# 53-41-8); (M+NA)+
ME195193
Androsterone
19.854
290.2248
Reversed phase POSITIVE ION MODE
CORTICOSTERONE (CAS# 50-22-6); (M+H)+
ME195241
Corticosterone
15.407
346.2123
Reversed phase POSITIVE ION MODE
CORTICOSTERONE (CAS# 50-22-6); (M+NA)+
ME195242
Corticosterone
15.387
346.2167
Reversed phase POSITIVE ION MODE
CORTISOL 21-ACETATE (CAS# 50-03-3); (M+H)+[-H2O]
ME195243
Cortisol 21-acetate
15.802
404.2224
Reversed phase POSITIVE ION MODE
CORTISOL 21-ACETATE (CAS# 50-03-3); (M+NA)+
ME195244
Cortisol 21-acetate
15.419
404.2181
Reversed phase POSITIVE ION MODE
EPIANDROSTERONE (CAS# 481-29-8); (M+H)+[-H2O]
ME195297
Epiandrosterone
18.365
290.2224
Reversed phase POSITIVE ION MODE
EPIANDROSTERONE (CAS# 481-29-8); (M+NA)+
ME195298
Epiandrosterone
18.482
290.2258
Reversed phase POSITIVE ION MODE
ESTRADIOL-17BETA (CAS# 50-28-2); (M+NA)+
ME195300
beta-Estradiol
16.401
272.1798
Reversed phase POSITIVE ION MODE
ESTRONE (CAS# 53-16-7); (M+H)+
ME195301
Estrone
16.335
270.1609
Reversed phase POSITIVE ION MODE
ESTRONE (CAS# 53-16-7); (M+NA)+
ME195302
Estrone
16.236
270.1601
Reversed phase POSITIVE ION MODE
PROGESTERONE (CAS# 57-83-0); (M+H)+
ME195498
Progesterone
19.807
314.2216
Reversed phase POSITIVE ION MODE
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel